Opening Day: Sionna Therapeutics, Titan America make public debut
Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...
At long last, U.S. Highway 212 expansion breaks ground
After more than a decade of planning, a 4.5-mile portion of U.S. Highway 212’s four-lane expansion has begun.Stretching from Cologne (Highway 36) to Carver (Highway 11/Jonathan Carver ...
Press release: Leonteq appoints Christian Spieler as CEO
Leonteq AG (SIX: LEON) today announced the appointment of Christian Spieler as Leonteq’s CEO effective 1 March 2025.
Bank of England Poised to Cut Rates but Inflation Worries Linger
The Bank of England looks set to cut interest rates on Thursday for only the third time since just after the start of the ...
Citi is bucking the RTO trend and sticking to 3 days a week in the office, even as it spends $1.2 billion on a new London office
As rival banks like JPMorgan and Goldman Sachs mandate five days in the office, Citi sees its hybrid schedule as a key ...
stockhead3d
Health Check: Ahead of Chemist Warehouse merger, brokers ring bell on ‘overvalued’ Sigma shares
Ahead of next week's merger with Chemist Warehouse, Sigma Healthcare shares are being called out as overvalued by some ...
Expense Control Will Be Key to Citi's Turnaround Efforts; Increasing FVE to $75 from $70
The commercial banking operation is Citi's most unique business, as its global footprint is hard to replicate. This international presence will help Citigroup remain a bank of choice for cross-border ...
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...
Initial ranking gives top score to former law school building for Citizens future location
The former Florida Coastal School of Law building got the top score in the first phase of Citizens Property Insurance's ...
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research ...
Q3 EPS Forecast for Arrowhead Pharmaceuticals Cut by Analyst
Stock analysts at Leerink Partnrs reduced their Q3 2025 earnings per share estimates for Arrowhead Pharmaceuticals in a ...
Seeking Alpha14d
Citigroup: Progress Made, But Much Is Still To Be Done
Citigroup has shown significant progress in ... Exiting the expense-intensive phase of its operational restructuring, Citi looks set to drive meaningful revenue growth on improved competitive ...